Stereotaxis, Inc. $STXS
Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.
Snapshot
- Exchange
- NYSE American
- Sector
- Electromedical & Electrotherapeutic Apparatus
- Headquarters
- St.Louis, MO
- Fiscal year end
- December 31
- Shares outstanding
- 100,202,178 [10-Q 2026-08-12]
What the company doesAI summary of filing
The provided text does not contain the actual Item 1. Business section content needed to complete this summary. [10-K 2026-03-12]
Financial health
| Period | Revenue | Net income | Operating cash flow | Cash | Filing |
|---|---|---|---|---|---|
| 6 months to Jun 2026 | $13.96M | −$10.33M | −$7.12M | $10.49M | [10-Q 2026-08-12] |
| FY ended Dec 2025 | $32.38M | −$21.64M | −$13.69M | $13.42M | [10-K 2026-03-12] |
| FY ended Dec 2024 | $26.92M | −$24.05M | −$8.50M | $12.22M | [10-K 2026-03-12] |
- Quarterly cash burn
- −$3.56M
- Cash runway Estimate
- ~8.8 months
Capital structure and dilution
| Date | Shares outstanding | Filing |
|---|---|---|
| 2024-10-31 | 84,729,507 | [10-Q 2024-11-14] |
| 2025-02-28 | 85,979,662 | [10-K 2025-03-14] |
| 2025-04-30 | 86,000,849 | [10-Q 2025-05-13] |
| 2025-07-31 | 90,653,769 | [10-Q 2025-08-13] |
| 2025-10-31 | 93,324,763 | [10-Q 2025-11-12] |
| 2026-02-28 | 97,248,936 | [10-K/A 2026-04-03] |
| 2026-04-30 | 97,736,700 | [10-Q 2026-05-13] |
| 2026-07-31 | 100,202,178 | [10-Q 2026-08-12] |
- Shelf registration
- S-3 filed 2026-07-15; declared effective 2026-08-13 [S-3 2026-07-15]
Listing status
Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.
Who owns it
| Date | Insider | Type | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-07-01 | Shamir Nachum | grant | 43,103 | — | [4 2026-07-01] |
| 2026-07-01 | Benfer David | grant | 43,103 | — | [4 2026-07-01] |
| 2026-07-01 | Levin Ross B | grant | 43,103 | — | [4 2026-07-01] |
| 2026-07-01 | Curet Myriam | grant | 43,103 | — | [4 2026-07-01] |
| 2026-07-01 | Fischel Nathan | grant | 43,103 | — | [4 2026-07-01] |
| 2026-07-01 | Menawat Arun Swarup | grant | 43,103 | — | [4 2026-07-01] |
| 2026-01-02 | Menawat Arun Swarup | grant | 46,948 | — | [4 2026-01-02] |
Catalysts and calendar
| Date | Type | Title |
|---|---|---|
| 2026-08-19 | 13G | Beneficial ownership report (5%+ holder) |
| 2026-08-13 | 424B3 | Prospectus or prospectus supplement |
| 2026-08-13 | 424B3 | Prospectus or prospectus supplement |
| 2026-08-12 | 10-Q | Quarterly report |
| 2026-08-11 | 8-K | Results of operations |
| 2026-07-16 | 8-K | Other events |
| 2026-07-15 | S-3 | Registration statement |
| 2026-07-15 | S-3 | Registration statement |
| 2026-07-09 | 8-K | Unregistered sale of equity; Regulation FD disclosure; Other events |
| 2026-05-15 | 13G/A | Beneficial ownership report (5%+ holder) |
| 2026-05-15 | 8-K | Shareholder vote results |
| 2026-05-13 | 10-Q | Quarterly report |
Alerts for $STXS
Email me when Stereotaxis, Inc. files an offering, gets a deficiency notice, or moves sharply.
Facts as of . Small caps move fast; check the latest filings.